Effect of Moisturizing Creams on Skin Barrier Function

ACO Hud Nordic

Status and phase

Unknown

Phase 4

Conditions

Atopic Eczema

Treatments

Drug: Placebo

Drug: urea/lactic acid

Study type

Interventional

Funder types

Industry

Identifiers

NCT00771121

ACO2008-CT-01

Details and patient eligibility

About

This study is a randomized, double-blind, placebo-controlled bilateral study on the effect of moisturizing creams on skin barrier function. The hypothesis is that a new active emulsion has a better influence on skin barrier function comapred to its placebo.

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Dry skin barrier disorders such as atopic dermatitis or Malassezia eradicated head and neck dermatitis.
Rough or clinically normal skin on the volar aspect of the forearm.
Either gender
Age between 18 and 65 years
Written Informed Consent

Exclusion criteria

Possible allergy to ingredients in the study medications.
Use of any concomitant medication that may interfere with the study related activities or assessment of efficacy.
Any patient related factor suggesting potential poor compliance with study procedures (e.g. psychiatric disorders, history of alcohol or substance abuse).
Any serious medical condition which, in the opinion of the investigator, may interfere with the evaluation of the results.
Pregnancy or breast feeding, or patients who plan to become pregnant during the course of the study.